Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP

Dr. Robert Grant weighs in after the first case of failed PrEP: What does it mean?

Editor's pick
BETA blog
26 February 2016
PrEP science

Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016

News
25 February 2016
Cancer

Early antiretroviral therapy reduces the risk of infection-related cancers

News
25 February 2016
Starting treatment

Removing clinic barriers to rapid initiation of ART in Uganda enables 70% to start on the same day

News
25 February 2016
HIV treatment for children & young people

Dolutegravir safe and highly effective in older children

News
25 February 2016
New & experimental HIV treatments

TAF/emtricitabine maintains viral suppression as well as TDF regimens with less bone and kidney toxicity

News
25 February 2016
PrEP

What is a drug “tail,” and what does it have to do with long-acting PrEP?

Editor's pick
BETA blog
25 February 2016
Hepatitis C treatment

New recommendations in the updated WHO guidelines for the screening, care and treatment of persons with chronic hepatitis C infection

Editor's pick
World Health Organization
25 February 2016
Global health targets

Botswana close to reaching the 90-90-90 testing and treatment targets

News
25 February 2016
Starting treatment

Starting HIV treatment at first clinic visit improves outcomes in African study

News
24 February 2016
New & experimental HIV treatments

Gilead announces results from first study to evaluate switching to FTAF-based regimens from Truvada® (FTDF)-based regimens

Editor's pick
Gilead press release
24 February 2016
PrEP science

Bone density recovers quickly after stopping PrEP

News
24 February 2016
New & experimental HIV treatments

Dose-finding trials of antibody-based drugs for HIV prevention will start soon

News
24 February 2016
New & experimental HIV treatments

Long-acting injectable cabotegravir + rilpivirine works well as HIV maintenance therapy

News
23 February 2016
Cardiovascular disease

Early antiretroviral therapy has no impact on marker of early cardiovascular disease

News
23 February 2016
Bone & joint problems

Tenofovir treatment raises the risk of broken bones

News
23 February 2016
New & experimental HIV treatments

Once-daily Isentress non-inferior to twice-daily dose

Editor's pick
Merck press release
22 February 2016
Adherence

Adherence State of Mind

Editor's pick
Beyond Positive
18 February 2016
Treatment outcomes & life expectancy

Older People With HIV Have Longer, But Still Limited Lifespan

Editor's pick
AIDSMeds
18 February 2016
The biology of HIV transmission

HIV-infected vaginal cells do not transmit HIV if plasma viral load is undetectable, researchers find

News
15 February 2016
Starting treatment

Dumbing down HIV treatment hurts everybody

Editor's pick
Positive Lite
11 February 2016
Health monitoring in resource-limited settings

HIV and drug resistance

Editor's pick
UNAIDS
9 February 2016
Retention & linkage to care

African Americans have highest HIV incidence, lowest rate of consistent care

News
8 February 2016
Women

Women under-represented in HIV clinical trials

News
8 February 2016